With multiple drugs nearing expiration over the next 5 years, pharmaceutical companies face intense competition and a potential $22 billion market opportunity. Strategic ANDA filings have become crucial to secure early mover advantage and maximize returns from leading drug innovations.

This report will help you identify – 

• Soon-to-expire blockbuster drugs – Identify top drugs losing patent protection in the next 5 years. 

• Patent Activity Trends – Get insights into potential hurdles and launch windows through patent analysis.

• Emerging Generic Markets – Identify countries set to become emerging markets for generics and biosimilars.

• Innovative Drug Leaders – Monitor top players to estimate the upcoming generic competition.